2-Methoxymethyl Montelukast 1,2-Diol (Mixture of Diastereomers)
![]() |
- $501.59 - $970
- Product name: 2-Methoxymethyl Montelukast 1,2-Diol (Mixture of Diastereomers)
- CAS: 184764-27-0
- MF: C37H40ClNO5S
- MW: 646.24
- EINECS:
- MDL Number:MFCD23160215
- Synonyms:2-Methoxymethyl Montelukast 1,2-Diol (Mixture of Diastereomers);1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-[1-hydroxy-2-(MethoxyMethoxy)-1-Methylethyl]phenyl]propyl]thio]Methyl]cyclopropaneacetic Acid;Montelukast Methoxymethoxy Impurity;2-MethoxyMethyl Montelukast 1,2-Diol;Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-[1-hydroxy-2-(methoxymethoxy)-1-methylethyl]phenyl]propyl]thio]methyl]-
2 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- TRC
Package
- 5MG
- 10mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberMTB0001014
- Product description2-METHOXYMETHYL MONTELUKAST-1,2-DIOL 95.00%
- Packaging5MG
- Price$501.59
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM264520
- Product description2-MethoxymethylMontelukast1,2-Diol(MixtureofDiastereomers)
- Packaging10mg
- Price$970
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | MTB0001014 | 2-METHOXYMETHYL MONTELUKAST-1,2-DIOL 95.00% | 5MG | $501.59 | 2021-12-16 | Buy |
TRC | M264520 | 2-MethoxymethylMontelukast1,2-Diol(MixtureofDiastereomers) | 10mg | $970 | 2021-12-16 | Buy |
Properties
Boiling point :785.0±60.0 °C(Predicted)
Density :1.275±0.06 g/cm3(Predicted)
solubility :Chloroform, Dichloromethane, Ethyl Acetate, Methanol
form :Yellow Semi-Solid
pka :4.76±0.10(Predicted)
Density :1.275±0.06 g/cm3(Predicted)
solubility :Chloroform, Dichloromethane, Ethyl Acetate, Methanol
form :Yellow Semi-Solid
pka :4.76±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|